Rosalind Advisors’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
Rosalind Advisors's AQST Position: Q3 2026 in Review
Rosalind Advisors increased its Aquestive Therapeutics (AQST) stake by 700% in Q3 2026, buying an estimated $7.78M and bringing the position to 2,000,000 shares worth $9.26M. The position accounts for 2.97% of the portfolio, ranked #11.
Rosalind Advisors first reported a position in AQST in Q1 2026 and has held it in 3 quarters since. 188 funds tracked by Wall St. Rank hold AQST as of Q3 2026.
- Rosalind Advisors held 2,000,000 shares of Aquestive Therapeutics worth $9.26M as of Q3 2026.
- Rosalind Advisors bought 1,750,000 Aquestive Therapeutics shares in Q3 2026, an estimated $7.78M.
- Aquestive Therapeutics made up 2.97% of Rosalind Advisors's portfolio in Q3 2026, its #11 holding.
- Rosalind Advisors first reported a position in Aquestive Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 188 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.
Based on Rosalind Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.